Ad
related to: squamous cell carcinoma
Search results
Adlai Nortye starts subject dosing in Phase II rectal cancer trial
Clinical Trials Arena via Yahoo Finance· 22 hours agoIn November last year, the company concluded the subject enrolment in the Phase III BURAN trial of...
The Current State Of Skin Cancer
Women s Health· 20 hours agoThe American Academy of Dermatology also points out that the rates of melanoma in people under 50 are higher in women than in men. “The incidence of...
High-Stage cSCC: Outcomes Superior With Mohs vs WLE
Medscape· 1 day agoMohs surgery appears to be superior to wide local excision (WLE) in patients with high-stage cutaneous squamous cell carcinoma (cSCC) ...
Protect your skin in the sun: A warning during Skin Cancer Awareness month
ABC 3340 Birmingham· 2 days agoAccording to the Skin Cancer Foundation 1 in 5 Americans will have skin cancer before the age of 70....
Glenmark to market BeiGene’s oncology medicines in India
Pharmaceutical Technology via Yahoo Finance· 3 days agoIt is under broad development for a range of cancer types. A small molecule inhibitor of Bruton’s...
Are you using sunscreen correctly?
Tribune via AOL· 5 days agoMay 18—Memorial Day weekend is on the horizon, and the unofficial start of summer brings promises of water, sun, splashing, grilled food and great fun with friends and family. And you have an ...
Rutgers Cancer Institute and RWJBarnabas Health Se | Newswise
Newswise· 1 day agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions...
Rutgers Cancer Institute and RWJBarnabas Health Set to Unveil Extensive, New Cancer Research...
WJTV Jackson· 12 hours agoClinicians and scientists from Rutgers Cancer Institute and RWJBarnabas Health will lead sessions and present their latest discoveries from their innovative cancer research program at the 2024 ...
Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of...
Digital Journal· 13 hours agoPhio is reporting on the completion of the first dose cohort for its on-going open-label Phase 1b clinical study (NCT 06014086) which is designed to evaluate the safety and tolerability of neoadjuvant ...
Immutep shares gain as CapitalOne sets $10 target on cancer drug potential By Investing.com
Investing.com· 7 days agoEfti is under evaluation in combination with standard of care therapies for various cancers,...
